MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (MDGL)
CUSIP: 558868105
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 22,822,754
- Total 13F shares
- 22,870,011
- Share change
- +1,759,992
- Total reported value
- $6,408,116,328
- Put/Call ratio
- 47%
- Price per share
- $280.16
- Number of holders
- 255
- Value change
- +$504,945,812
- Number of buys
- 154
- Number of sells
- 117
Quarterly Holders Quick Answers
What is CUSIP 558868105?
CUSIP 558868105 identifies MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 558868105:
Top shareholders of MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
11%
|
2,601,282
|
$694,526,099 | — | 31 Mar 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
8.6%
|
1,969,798
|
$526,014,858 | — | 31 Mar 2024 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
8.5%
|
1,944,444
|
$519,244,326 | — | 31 Mar 2024 | |
| PAULSON & CO. INC. |
13F
|
Company |
7.8%
|
1,775,000
|
$473,996,000 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
7.3%
|
1,668,806
|
$445,637,954 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.3%
|
1,210,391
|
$323,222,813 | — | 31 Mar 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
3.5%
|
803,213
|
$214,491,000 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
3.1%
|
713,914
|
$190,643,595 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.7%
|
624,938
|
$166,883,444 | — | 31 Mar 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.9%
|
429,953
|
$114,814,649 | — | 31 Mar 2024 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
1.8%
|
401,709
|
$107,272,371 | — | 31 Mar 2024 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
1.7%
|
397,047
|
$106,027,431 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
346,857
|
$92,638,421 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.3%
|
288,606
|
$77,069,442 | — | 31 Mar 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
1.3%
|
285,931
|
$76,355,014 | — | 31 Mar 2024 | |
| Erste Asset Management GmbH |
13F
|
Company |
1.1%
|
250,625
|
$66,576,302 | — | 31 Mar 2024 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
0.9%
|
204,500
|
$54,609,680 | — | 31 Mar 2024 | |
| Bain Capital Life Sciences Investors, LLC |
13F
|
Company |
0.86%
|
196,995
|
$52,605,545 | — | 31 Mar 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.81%
|
184,163
|
$48,426,921 | — | 31 Mar 2024 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
0.74%
|
168,000
|
$44,862,720 | — | 31 Mar 2024 | |
| TCG Crossover Management, LLC |
13F
|
Company |
0.65%
|
149,283
|
$39,864,532 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.58%
|
131,358
|
$35,077,840 | — | 31 Mar 2024 | |
| Tao Capital Management LP |
13F
|
Company |
0.57%
|
130,529
|
$34,856,464 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.55%
|
125,415
|
$33,490,822 | — | 31 Mar 2024 | |
| Polar Capital Holdings Plc |
13F
|
Company |
0.55%
|
125,205
|
$33,434,743 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.54%
|
122,692
|
$32,763,672 | — | 31 Mar 2024 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.5%
|
115,000
|
$30,709,600 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.5%
|
113,114
|
$30,205,962 | — | 31 Mar 2024 | |
| Artal Group S.A. |
13F
|
Company |
0.48%
|
110,507
|
$29,509,789 | — | 31 Mar 2024 | |
| Rheos Capital Works Inc. |
13F
|
Company |
0.48%
|
110,215
|
$29,432,000 | — | 31 Mar 2024 | |
| AlpInvest Partners B.V. |
13F
|
Company |
0.46%
|
105,744
|
$28,237,878 | — | 31 Mar 2024 | |
| EMERALD ADVISERS, LLC |
13F
|
Company |
0.45%
|
101,623
|
$27,137,406 | — | 31 Mar 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.43%
|
97,752
|
$26,103,883 | — | 31 Mar 2024 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.43%
|
97,103
|
$25,931,000 | — | 31 Mar 2024 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.41%
|
93,597
|
$24,994,143 | — | 31 Mar 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.41%
|
93,571
|
$24,987,200 | — | 31 Mar 2024 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.4%
|
92,218
|
$24,625,894 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.4%
|
91,789
|
$24,511,349 | — | 31 Mar 2024 | |
| Mirae Asset Global Investments Co., Ltd. |
13F
|
Company |
0.4%
|
92,253
|
$24,480,503 | — | 31 Mar 2024 | |
| NORGES BANK |
13F
|
Company |
0.39%
|
89,950
|
$24,020,248 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.35%
|
80,192
|
$21,414,472 | — | 31 Mar 2024 | |
| EMERALD MUTUAL FUND ADVISERS TRUST |
13F
|
Company |
0.33%
|
75,759
|
$20,230,683 | — | 31 Mar 2024 | |
| EcoR1 Capital, LLC |
13F
|
Company |
0.33%
|
75,000
|
$20,028,000 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.31%
|
70,712
|
$18,879,155 | — | 31 Mar 2024 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.28%
|
64,576
|
$17,244,375 | — | 31 Mar 2024 | |
| MPM BioImpact LLC |
13F
|
Company |
0.27%
|
61,399
|
$16,395,989 | — | 31 Mar 2024 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.26%
|
58,957
|
$15,744,000 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.25%
|
57,883
|
$15,457,160 | — | 31 Mar 2024 | |
| University of Wisconsin Foundation |
13F
|
Company |
0.25%
|
56,376
|
$15,054,647 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.24%
|
55,404
|
$14,795,084 | — | 31 Mar 2024 |
Institutional Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (MDGL) as of Q2 2024
As of 30 Jun 2024,
MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (MDGL) was held by
255 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,870,011 shares.
The largest 10 holders included
JANUS HENDERSON GROUP PLC, Avoro Capital Advisors LLC, BAKER BROS. ADVISORS LP, RTW INVESTMENTS, LP, PAULSON & CO. INC., VANGUARD GROUP INC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, and STATE STREET CORP.
This page lists
256
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
263
Q2 2024 holders
255
Holder diff
-8
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.